solver.press

Evolutionary trade-offs in antibiotic resistance can be modeled and predicted using computational equilibrium concepts from game theory.

BiologyMay 4, 2026Evaluation Score: 63%

Adversarial Debate Score

62% survival rate under critique

Model Critiques

google: Falsifiable and supported by the papers showing trade-offs, but the complexity of evolutionary systems might limit the accuracy and scope of game theory models.
openai: The hypothesis is falsifiable and intriguing, as evolutionary trade-offs are well documented and game theory offers a structured modeling framework. However, while the cited papers support the existence of trade-offs, they do not specifically validate the predictive power of computational equilib...
grok: The hypothesis is falsifiable and supported by papers showing evolutionary trade-offs in antibiotic resistance, which could be modeled using game theory's equilibrium concepts. However, the direct application of computational game theory to predict these trade-offs lacks explicit evidence in the ...
mistral: The hypothesis is falsifiable and aligns with evidence of trade-offs in resistance, but counterarguments (e.g., compensatory mutations, ecological complexity) weaken its predictive power without further refinement. Game-theoretic models may oversimplify dynamic evolutionary processes.
anthropic: The hypothesis has a plausible biological foundation—the papers robustly document that resistance trade-offs exist—but none of the excerpts actually employ game-theoretic equilibrium modeling to predict these trade-offs, leaving the computational claim unsupported and largely speculative; additio...

Supporting Research Papers

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Computational game-theoretic equilibrium models (specifically Nash Equilibrium and Evolutionary Stable Strategy frameworks) can predict the frequency and magnitude of fitness trade-offs in antibiotic-resistant bacterial populations with statistically significant accuracy (R² ≥ 0.70, p < 0.05) compared to empirically measured resistance-fitness cost data across ≥3 antibiotic classes and ≥5 bacterial species, outperforming null models (random drift, simple logistic growth) by a margin of ≥15% in predictive accuracy.

Disproof criteria:
  1. Game-theoretic equilibrium predictions fail to outperform a null logistic growth model (R² difference < 0.05) across ≥3 independent bacterial species/antibiotic combinations.
  2. Predicted Nash Equilibria do not correspond to observed stable population frequencies in ≥70% of experimental replicates (p > 0.05 by chi-square goodness-of-fit).
  3. Fitness trade-off magnitudes predicted by the model deviate from empirical measurements by >30% mean absolute percentage error (MAPE) consistently across datasets.
  4. Evolutionary Stable Strategies predicted by the model are invaded by alternative strategies in >40% of experimental evolution runs (≥20 replicates, ≥100 generations each).
  5. Model requires >5 free parameters per species/antibiotic pair to achieve R² ≥ 0.70, indicating overfitting rather than genuine predictive power.
  6. Predictions fail to generalize across antibiotic classes (e.g., accurate for beta-lactams but not fluoroquinolones), suggesting class-specific artifacts rather than universal principles.

Experimental Protocol

PHASE 1 — Model Construction (Weeks 1–4): Build payoff matrices for 3 bacterial species (E. coli, S. aureus, P. aeruginosa) × 3 antibiotic classes (beta-lactams, fluoroquinolones, aminoglycosides) using published MIC and growth rate data. Implement Nash Equilibrium solver and Replicator Dynamics simulation. Parameterize fitness costs from literature (n ≥ 50 published competition assays per species).

PHASE 2 — In Silico Validation (Weeks 5–8): Run replicator dynamics simulations (10,000 iterations per condition) to predict equilibrium frequencies. Compare predictions against 3 published longitudinal evolution datasets (LTEE, PATRIC database, EUCAST surveillance data). Compute R², MAPE, and Brier scores.

PHASE 3 — Prospective Experimental Validation (Weeks 9–20): Conduct 96-well plate competition assays: 3 species × 3 antibiotics × 4 resistance mechanisms × 8 replicates = 288 experimental units. Measure growth rates at 0, 24, 48, 72 hours. Sequence resistant isolates (Illumina short-read, n=96) to confirm resistance genotypes. Compare observed equilibrium frequencies at generation 50 and 100 against model predictions.

PHASE 4 — Predictive Generalization Test (Weeks 21–24): Apply model trained on E. coli/beta-lactam data to predict outcomes in K. pneumoniae/carbapenem system (held-out validation). Assess transfer accuracy.

Required datasets:
  1. PATRIC (Pathosystems Resource Integration Center) — resistance phenotype + genotype data for >500,000 bacterial isolates (free, public).
  2. LTEE (Long-Term Evolution Experiment) — Lenski lab E. coli fitness trajectory data, 75,000 generations (free, public).
  3. EUCAST MIC distribution tables — species-specific MIC breakpoints and distributions (free, public).
  4. CARD (Comprehensive Antibiotic Resistance Database) — resistance gene ontology and mechanism data (free, public).
  5. Published competition assay datasets: Andersson & Hughes (2010), Melnyk et al. (2015), Vogwill & MacLean (2015) — fitness cost meta-analysis data.
  6. Custom experimental data: 288 competition assay measurements (generated in Phase 3).
  7. Whole-genome sequencing data: 96 isolates × ~5 Mb genome = ~480 Mb raw data (generated in Phase 3).
  8. Game theory solver: Nashpy (Python), Gambit software suite (free, open-source).
Success:
  1. R² ≥ 0.70 between predicted and observed equilibrium frequencies across ≥18/27 species-antibiotic conditions (p < 0.05, permutation test).
  2. MAPE ≤ 20% for fitness trade-off magnitude predictions across all experimental conditions.
  3. Nash Equilibrium predictions match observed stable population frequencies within ±10% in ≥75% of experimental replicates (288 assays).
  4. Game-theoretic model outperforms logistic growth null model by ≥15% in R² across all conditions.
  5. Evolutionary Stable Strategies correctly predict invasion resistance in ≥80% of experimental evolution replicates.
  6. Model generalizes to held-out K. pneumoniae/carbapenem system with R² ≥ 0.60 (transfer accuracy criterion).
  7. Bayesian posterior predictive intervals capture observed data in ≥90% of cases (calibration criterion).
  8. Sensitivity analysis shows model is robust to ±20% parameter perturbation (prediction change < 15%).
Failure:
  1. R² < 0.50 across ≥50% of species-antibiotic conditions after full parameterization.
  2. MAPE > 35% for fitness trade-off predictions in ≥2 of 3 bacterial species.
  3. Game-theoretic model performs no better than random frequency assignment (p > 0.10 on permutation test) in ≥3 conditions.
  4. 40% of predicted Nash Equilibria are not observed experimentally (chi-square p < 0.05 for deviation).

  5. Model requires >8 free parameters per condition to achieve R² ≥ 0.60, indicating overfitting.
  6. Transfer to K. pneumoniae/carbapenem system yields R² < 0.40, indicating no generalization.
  7. Contamination or plasmid transfer events invalidate >20% of competition assay replicates.
  8. Sequencing reveals unexpected resistance mechanisms in >30% of isolates, invalidating payoff matrix assumptions.

48

GPU hours

168d

Time to result

$18,500

Min cost

$87,000

Full cost

ROI Projection

Commercial:
  1. DIAGNOSTIC TOOLS: Resistance evolution prediction software for clinical microbiology labs; market size ~$1.2B (antimicrobial susceptibility testing market, 2023); potential SaaS licensing at $50K–200K per hospital system annually.
  2. PHARMACEUTICAL: Antibiotic combination optimization platform for pharma R&D; licensing value $5–50M per partnership; applicable to 15+ companies with active antibiotic pipelines.
  3. HOSPITAL SYSTEMS: Infection control decision support integration into EMR systems (Epic, Cerner); potential $10–30M acquisition target for health IT companies.
  4. AGRICULTURAL: Veterinary antibiotic stewardship applications (livestock resistance management); $800M global veterinary antimicrobial market.
  5. BIODEFENSE: BARDA/DoD interest in resistance prediction for biodefense preparedness; contract value $2–10M.
  6. ACADEMIC LICENSING: Software toolkit licensing to research institutions; $500K–2M cumulative over 10 years.
  7. TOTAL ADDRESSABLE MARKET (conservative): $50–200M over 10 years if commercialized as integrated resistance prediction platform.

🔓 If proven, this unlocks

Proving this hypothesis is a prerequisite for the following downstream discoveries and applications:

  • 1adaptive-antibiotic-cycling-game-theoretic-optimization
  • 2personalized-resistance-evolution-prediction-clinical
  • 3multi-drug-combination-nash-equilibrium-therapy-design
  • 4evolutionary-trap-antibiotic-resistance-reversal
  • 5game-theoretic-hospital-infection-control-policy
  • 6resistance-evolution-forecasting-surveillance-integration

Prerequisites

These must be validated before this hypothesis can be confirmed:

  • empirical-fitness-cost-database-antibiotic-resistance-2024
  • game-theory-evolutionary-dynamics-microbial-validation
  • patric-resistance-phenotype-genotype-linkage-study
  • ltee-fitness-trajectory-quantification-2023

Implementation Sketch

# Evolutionary Game Theory - Antibiotic Resistance Prediction Framework
# Architecture Overview

import numpy as np
import nashpy as nash
from scipy.integrate import odeint
import pymc3 as pm
from sklearn.metrics import r2_score, mean_absolute_percentage_error

# ============================================================
# MODULE 1: PAYOFF MATRIX CONSTRUCTION
# ============================================================
class ResistancePayoffMatrix:
    """
    Constructs payoff matrices from empirical fitness cost data.
    Strategies: [Susceptible, Resistant, Compensatory_Mutant, Multi_Resistant]
    """
    def __init__(self, species, antibiotic_class):
        self.species = species
        self.antibiotic_class = antibiotic_class
        self.strategies = ['S', 'R', 'CM', 'MR']
        
    def build_from_literature(self, fitness_cost_db):
        # fitness_cost_db: DataFrame with columns [species, mechanism, growth_rate, MIC]
        # Returns: NxN payoff matrix where entry [i,j] = fitness of strategy i vs strategy j
        payoff_matrix = np.zeros((4, 4))
        for i, strat_i in enumerate(self.strategies):
            for j, strat_j in enumerate(self.strategies):
                payoff_matrix[i,j] = self._compute_payoff(
                    strat_i, strat_j, fitness_cost_db
                )
        return payoff_matrix
    
    def _compute_payoff(self, s_i, s_j, db):
        # Payoff = growth_rate_i * (1 - fitness_cost_i) * antibiotic_effect(s_i, s_j)
        # antibiotic_effect depends on MIC ratio and environmental antibiotic concentration
        base_growth = db.loc[(db.species==self.species) & 
                              (db.strategy==s_i), 'growth_rate'].mean()
        fitness_cost = db.loc[(db.species==self.species) & 
                               (db.strategy==s_i), 'fitness_cost'].mean()
        mic_ratio = self._get_mic_ratio(s_i, s_j, db)
        return base_growth * (1 - fitness_cost) * mic_ratio

# ============================================================
# MODULE 2: NASH EQUILIBRIUM SOLVER
# ============================================================
class NashEquilibriumSolver:
    def __init__(self, payoff_matrix_A, payoff_matrix_B=None):
        # For symmetric games, B = A.T
        self.A = payoff_matrix_A
        self.B = payoff_matrix_B if payoff_matrix_B is not None else payoff_matrix_A.T
        self.game = nash.Game(self.A, self.B)
    
    def find_all_equilibria(self):
        equilibria = list(self.game.support_enumeration())
        return equilibria  # List of (sigma_1, sigma_2) mixed strategy pairs
    
    def find_ess(self, equilibria):
        # Evolutionary Stable Strategy: NE that satisfies second-order stability
        ess_candidates = []
        for eq in equilibria:
            sigma = eq[0]
            if self._is_ess(sigma):
                ess_candidates.append(sigma)
        return ess_candidates
    
    def _is_ess(self, sigma):
        # ESS condition: for all mutant strategies m != sigma,
        # u(sigma, sigma) > u(m, sigma) OR
        # [u(sigma, sigma) == u(m, sigma) AND u(sigma, m) > u(m, m)]
        n_strategies = len(sigma)
        for mutant_idx in range(n_strategies):
            if sigma[mutant_idx] < 1e-6:  # Not in support
                mutant = np.zeros(n_strategies)
                mutant[mutant_idx] = 1.0
                u_sigma_sigma = sigma @ self.A @ sigma
                u_mutant_sigma = mutant @ self.A @ sigma
                if u_mutant_sigma >= u_sigma_sigma:
                    return False
        return True

# ============================================================
# MODULE 3: REPLICATOR DYNAMICS SIMULATION
# ============================================================
class ReplicatorDynamics:
    def __init__(self, payoff_matrix, n_strategies):
        self.A = payoff_matrix
        self.n = n_strategies
    
    def dynamics(self, x, t):
        # dx_i/dt = x_i * [(Ax)_i - x^T A x]
        Ax = self.A @ x
        avg_fitness = x @ Ax
        dxdt = x * (Ax - avg_fitness)
        return dxdt
    
    def simulate(self, x0, t_span, n_points=1000):
        t = np.linspace(0, t_span, n_points)
        trajectory = odeint(self.dynamics, x0, t)
        equilibrium = trajectory[-1]  # Final state
        return trajectory, equilibrium
    
    def run_ensemble(self, n_initial_conditions=100, t_span=500):
        equilibria = []
        for _ in range(n_initial_conditions):
            # Random initial frequencies (Dirichlet distribution)
            x0 = np.random.dirichlet(np.ones(self.n))
            _, eq = self.simulate(x0, t_span)
            equilibria.append(eq)
        return np.array(equilibria)

# ============================================================
# MODULE 4: BAYESIAN PARAMETER ESTIMATION
# ============================================================
class BayesianPayoffEstimator:
    def __init__(self, observed_frequencies, prior_fitness_costs):
        self.observed = observed_frequencies
        self.priors = prior_fitness_costs
    
    def fit(self, n_samples=2000, n_chains=4):
        with pm.Model() as model:
            # Priors on fitness costs from literature
            fitness_cost = pm.Normal('fitness_cost', 
                                      mu=self.priors['mean'], 
                                      sigma=self.priors['std'],
                                      shape=len(self.priors['mean']))
            # Likelihood: observed frequencies ~ Dirichlet(predicted_equilibrium)
            predicted_eq = pm.Deterministic('predicted_eq', 
                                             self._compute_equilibrium(fitness_cost))
            obs = pm.Dirichlet('obs', a=predicted_eq * 100, 
                                observed=self.observed)
            trace = pm.sample(n_samples, chains=n_chains, 
                               return_inferencedata=True)
        return trace
    
    def _compute_equilibrium(self, fitness_cost):
        # Differentiable equilibrium computation for gradient-based sampling
        # Simplified: returns softmax of fitness-adjusted payoffs
        adjusted_payoffs = pm.math.softmax(-fitness_cost)
        return adjusted_payoffs

# ============================================================
# MODULE 5: VALIDATION AND METRICS
# ============================================================
class ModelValidator:
    def __init__(self, predictions, observations):
        self.pred = predictions
        self.obs = observations
    
    def compute_metrics(self):
        metrics = {
            'r2': r2_score(self.obs, self.pred),
            'mape': mean_absolute_percentage_error(self.obs, self.pred),
            'pearson_r': np.corrcoef(self.obs, self.pred)[0,1],
            'mean_abs_error': np.mean(np.abs(self.obs - self.pred))
        }
        return metrics
    
    def permutation_test(self, n_permutations=10000):
        observed_r2 = r2_score(self.obs, self.pred)
        null_r2s = []
        for _ in range(n_permutations):
            shuffled_pred = np.random.permutation(self.pred)
            null_r2s.append(r2_score(self.obs, shuffled_pred))
        p_value = np.mean(np.array(null_r2s) >= observed_r2)
        return p_value, observed_r2, np.array(null_r2s)
    
    def compare_to_null_model(self, null_predictions):
        null_r2 = r2_score(self.obs, null_predictions)
        model_r2 = r2_score(self.obs, self.pred)
        improvement = (model_r2 - null_r2) / max(abs(null_r2), 1e-6)
        return {'null_r2': null_r2, 'model_r2': model_r2, 
                'relative_improvement': improvement}

# ============================================================
# MODULE 6: MAIN PIPELINE
# ============================================================
def run_validation_pipeline(species_list, antibiotic_list, fitness_db, 
                              experimental_data):
    results = {}
    for species in species_list:  # ['E.coli', 'S.aureus', 'P.aeruginosa']
        for antibiotic in antibiotic_list:  # ['beta-lactam', 'fluoroquinolone', 'aminoglycoside']
            condition = f"{species}_{antibiotic}"
            
            # Step 1: Build payoff matrix
            rpm = ResistancePayoffMatrix(species, antibiotic)
            A = rpm.build_from_literature(fitness_db)
            
            # Step 2: Find Nash Equilibria
            nes = NashEquilibriumSolver(A)
            equilibria = nes.find_all_equilibria()
            ess = nes.find_ess(equilibria)
            
            # Step 3: Simulate replicator dynamics
            rd = ReplicatorDynamics(A, n_strategies=4)
            trajectories = rd.run_ensemble(n_initial_conditions=100)
            predicted_eq = np.median(trajectories, axis=0)
            
            # Step 4: Bayesian refinement
            obs_freq = experimental_data[condition]['frequencies']
            priors = fitness_db.get_priors(species, antibiotic)
            bpe = BayesianPayoffEstimator(obs_freq, priors)
            trace = bpe.fit()
            
            # Step 5: Validate
            validator = ModelValidator(predicted_eq, obs_freq)
            metrics = validator.compute_metrics()
            p_val, obs_r2, null_dist = validator.permutation_test()
            
            results[condition] = {
                'nash_equilibria': equilibria,
                'ess': ess,
                'predicted_frequencies': predicted_eq,
                'metrics': metrics,
                'p_value': p_val,
                'bayesian_trace': trace
            }
    
    return results

# ============================================================
# EXECUTION
# ============================================================
# species_list = ['E.coli', 'S.aureus', 'P.aeruginosa']
# antibiotic_list = ['beta-lactam', 'fluoroquinolone', 'aminoglycoside']
# results = run_validation_pipeline(species_list, antibiotic_list, 
#                                    fitness_db, experimental_data)
# Generate summary report with all metrics and visualizations
Abort checkpoints:

CHECKPOINT 1 (End of Week 4 — Model Construction): ABORT IF: Nash Equilibrium solver fails to converge for >30% of payoff matrices derived from literature data, OR Bayesian parameter estimation yields posterior distributions with R-hat > 1.1 for >50% of parameters. ACTION: Simplify to 2-strategy games; reduce model dimensionality.

CHECKPOINT 2 (End of Week 8 — In Silico Validation): ABORT IF: R² < 0.40 against LTEE and PATRIC validation datasets across all conditions, OR game-theoretic model performs no better than null model (p > 0.20 on permutation test) in ≥5/9 conditions. ACTION: Reassess payoff matrix construction methodology; consider alternative equilibrium concepts (correlated equilibrium, quantal response equilibrium) before proceeding to wet lab.

CHECKPOINT 3 (End of Week 12 — Early Experimental Results): ABORT IF: >25% of competition assays show contamination or anomalous growth curves (OD600 trajectories inconsistent with expected growth phases), OR preliminary frequency measurements (n=48 assays) show MAPE > 50% against model predictions. ACTION: Troubleshoot assay protocol; replace contaminated strains; reassess whether experimental system matches model assumptions.

CHECKPOINT 4 (End of Week 16 — Full Experimental Dataset): ABORT IF: R² < 0.50 across ≥60% of species-antibiotic conditions with full experimental data, OR >35% of predicted Nash Equilibria are not observed experimentally. ACTION: Conduct root cause analysis; determine whether failure is in model structure, parameterization, or experimental system; consider publishing negative result with mechanistic explanation.

CHECKPOINT 5 (End of Week 20 — Sequencing Analysis): ABORT IF: Sequencing reveals that >30% of resistant isolates carry unexpected resistance mechanisms not present in payoff matrix (e.g., novel efflux pumps, unexpected plasmid acquisition), invalidating model assumptions. ACTION: Update payoff matrices with newly discovered mechanisms; re-run predictions; extend timeline by 4 weeks for model revision.

CHECKPOINT 6 (End of Week 23 — Transfer Validation): ABORT GENERALIZATION CLAIM IF: Transfer to K. pneumoniae/carbapenem system yields R² < 0.40. ACTION: Downgrade claim from "universal framework" to "species-specific model"; revise manuscript scope accordingly; do not abort entire study.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started